Irnocam 100 mg Injection
17.75$
13.90$
Irnocam 100 mg Injection is a powerful topoisomerase inhibitor specifically designed for the treatment of advanced colorectal cancer. This injectable medication is effective as a standalone therapy or can be used in conjunction with 5-fluorouracil and folinic acid, particularly for patients who have not undergone prior chemotherapy for their advanced disease. By disrupting the DNA replication process in cancer cells, Irnocam plays a critical role in managing metastatic carcinoma of the colon and rectum. While it offers significant therapeutic benefits, patients should be aware of potential side effects and consult their healthcare provider regarding any pre-existing conditions or medications that may interact with Irnocam. Regular monitoring during treatment is essential to ensure the best outcomes. For those seeking a reliable option in the fight against colorectal cancer, Irnocam 100 mg Injection stands out as a vital component of a comprehensive treatment plan. Always follow your healthcare provider’s instructions and report any adverse effects promptly for optimal care.
الكمية
Active Pharmaceutical Ingredient
Uses
• Irnocam 100 mg injection is primarily used in the treatment of various types of cancer. It is administered intravenously by healthcare professionals in a controlled environment. The medication plays a critical role in combination chemotherapy regimens, enhancing the effectiveness of other cancer treatments. This targeted approach helps to combat tumor growth and improve patient outcomes.
• The use of Irnocam 100 mg injection is often tailored to the specific type and stage of cancer being addressed. Oncologists evaluate individual patient factors to determine the most effective treatment plan. By integrating this injection into chemotherapy, healthcare providers aim to maximize therapeutic benefits while addressing the unique needs of each patient. This customization is essential for achieving optimal results in cancer care.
• Irnocam 100 mg injection is typically administered in a hospital or clinical setting, where patients can be closely monitored. The healthcare team ensures the proper administration of the drug, which is crucial for its effectiveness. This setting allows for immediate support and intervention if necessary, making it a safe option for patients undergoing chemotherapy. The clinical environment also provides patients with access to comprehensive care throughout their treatment journey.
• Patients receiving Irnocam 100 mg injection may be part of a broader treatment strategy that includes other medications and therapies. This injection is vital for enhancing the overall efficacy of the chemotherapy regimen. Oncologists often use this medication to target cancer cells more effectively while minimizing potential resistance. By incorporating Irnocam 100 mg injection, healthcare providers work towards improving survival rates and quality of life for cancer patients.
Benefits
Treatment of colon and rectum cancer: Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Irnocam 100 mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Irnocam 100 mg Vial can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Constipation
• Fever
• Infection
• Pain
Common Side Effects
• Diarrhea
• Kidney Impairment
• Lung Problems
• Low blood count
How To Use
Irnocam 100 mg Injection is administered by a qualified doctor or nurse at a hospital or clinical setting. It is given intravenously and is usually given as part of a combination chemotherapy regimen. The specific treatment plan and dosage will depend on the type and stage of the cancer being treated, as well as other individual factors determined by the healthcare provider.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Irnocam Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Irnocam 100 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Irnocam Injection and report any unusual symptoms or changes in kidney function to their doctor. Irnocam 100 mg Injection is not recommended for use in patients on dialysis.
• Breastfeeding: The available data are limited but suggested that Irnocam 100 mg Injection and its metabolite are excreted in human milk. Consequently, because of the potential for adverse reactions in nursing infants, breastfeeding should be discontinued for the duration of Irinotecan Injection 100 mg therapy.
• Liver: Irnocam 100 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Irnocam 100 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Irnocam Injection may need to be adjusted in patients with liver disease.
• Pregnancy: There are limited data on the use of irinotecan in pregnant women. Irnocam 100 mg has been shown to be embryotoxic and teratogenic in animals. Therefore, based on results from animal studies and the mechanism of action of Irnocam 100 mg, Irnocam 100 mg Vial should not be used during pregnancy unless clearly necessary. Women of childbearing potential should not be started on Irinotecan Injection 100 mg until pregnancy is excluded. Pregnancy should be avoided if either partner is receiving Irnocam 100 mg Vial.
• Driving: Irnocam 100 mg Injection has a moderate influence on the ability to drive and use machines. Patients should be warned about the potential for dizziness or visual disturbances which may occur within 24 hours following the administration of Irnocam 100 mg and advised not to drive or operate machinery if these symptoms occur.